ESR1 and breast cancer: Although I demonstrated that the expression levels of potential biomarkers are positively/negatively correlated with the aggressive and metastatic nature of breast cancer and are associated with clinical outcomes of breast cancer patients, their molecular functions except for CCNA2, PGR, and ESR1 have not been experimentally elucidated in breast carcinogenesis.